DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Taiho Pharmaceutical
Taiho Pharmaceutical
Otsuka Group Acquires ISO 14001 Certification -Reinforcement Of
Dear Participants of the 5Th World Congress on Alternatives And
Microrna Profiles Involved in Trifluridine Resistance
Taiho Pharmaceutical
Health Canada Approves Inqovi® (Decitabine And
Company Pr0file 2021
Otsuka Group Complete Introduction of CO2-Free Electricity for All 23 Manufacturing Facilities in Japan
The 5Th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2017)
How We Will Achieve Sustainability for More Details About Our Health-Related Initiatives, Visit: Health and People
Taiho Oncology Announces Agreement with Otsuka to Commercialize Astex Pharmaceuticals’ Drug Candidates
Otsuka Group CSR Report 2014/12
EXECUTIVE COMMITTEE President Shinya Saito, MD, Phd Professor
Company Profile 2020
Specific Distribution of TOP-53 to the Lung and Lung-Localized Tumor Is Determined by Its Interaction with Phospholipids
Advance in the Global Market As a Unique Total Healthcare Company —Five-Year Growth Phase (2019–2023)—
Tokushima(Fiscal Year 2003-2007)
Photo Credits
Corporate Profile
Top View
News Release
Taiho Oncology Names Timothy Whitten President
Scientific Programme
Versus Tumor Tissue Clinical Sequencing For
Otsuka Group Acquires ISO 14001 Certification -Reinforcement Of
Notice of the Reorganization of Three Otsuka Group Companies(Otsuka
Office Divisions of Five Otsuka Group Companies to Switch to Green Power
The TAIHO Group's Contribution to the Sdgs
List of Institutions Funding Cancer Research
Otsuka Group CSR Report 2012
Crine Secretion